Single answer
Is Armada Hoffler Properties Inc (AHRT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
American Healthcare REIT Inc is a selfmanaged real estate investment trust that acquires owns and operates a diversified portfolio of clinical healthcare real estate properties focusing primarily on outpatient medical buildings senior housing skilled nursing facilities and other healthcarerelated facilities Its properties are located in 36 states the United Kingdom and the Isle of Man
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.15 and is up 0.0100 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.69. Cash flow to debt ratio: 0.03. Net profit margin: 1.33%. Inflation risk score: high (0.80/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Armada Hoffler Properties Inc is $10.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Armada Hoffler Properties Inc 10 years ago, but if you had invested on 2026-02-05 when the price was $7.06, you would have made a loss of $1.120 per share or 15.86%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.